Outcomes of the five patients with Kawasaki disease relapse | Download Scientific Diagram
Kawasaki Disease | American Academy of Pediatrics
Full text] Refractory Kawasaki disease: diagnostic and management challenges | PHMT
PDF) Recurrent Kawasaki Disease: A Case Report of Three Separate Episodes at >4-Year Intervals
Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics
Kawasaki disease treatment algorithm - UpToDate
Kawasaki Disease: Heart Disease During Childhood | Revista Española de Cardiología
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML
Kawasaki Disease | Obgyn Key
Frontiers | The Epidemiology and Pathogenesis of Kawasaki Disease | Pediatrics
Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram
Kawasaki Disease: Practice Essentials, Background, Pathophysiology
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association
Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years
Recurrent lip swelling as a late presentation of Kawasaki disease: Case report and review of literature – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free
Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram
Kawasaki Disease
Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram
Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study | Pediatrics
Kawasaki's Disease
Kawasaki disease is a rare condition. It is most common in children under five years old and most cases occur in children aged between nine months and. - ppt download
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution
Kawasaki disease for dermatologists Gupta A, Singh S - Indian Dermatol Online J
PDF) Recurrent refractory Kawasaki disease
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation